POLR3G and non-small cell lung carcinoma: Consistent with these findings, our study revealed that the inhibition of POLR3G could counteract the enhancing effect of ZNF384 on the EMT of NSCLC cells, which indicated that the signaling pathway involving ZNF384 and POLR3G facilitated tumor cell migration, invasion, and EMT in NSCLC.